| Date Filed | Type | Description |
| 08/07/2023 |
4
| Renaud Ronald C JR (President & CEO) has filed a Form 4 on Cerevel Therapeutics Holdings, Inc.|
Txns:
| Bought 83,857 shares
@ $23.9552, valued at
$2M
|
|
| 06/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/23/2021 |
4
| Renaud Ronald C JR (Director) has filed a Form 4 on Ikena Oncology, Inc.|
Txns:
| Granted 13,419 options to buy
@ $14.92, valued at
$200.2k
|
|
| 09/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/14/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 06/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/25/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/18/2020 |
4
| Renaud Ronald C JR (CEO, Pres.) has filed a Form 4 on Translate Bio, Inc.|
Txns:
| Exercised 53,004 options to buy
@ $7.39, valued at
$391.7k
Exercised 3 options to buy
@ $8.34, valued at
$25 |
|
| 04/30/2020 |
4
| Renaud Ronald C JR (Director) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Granted 71,500 options to buy
@ $8.53, valued at
$609.9k
|
|
| 04/30/2020 |
3
| Renaud Ronald C JR (Director) has filed a Form 3 on Atara Biotherapeutics, Inc. |
| 03/05/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2019 |
4
| Renaud Ronald C JR (Director) has filed a Form 4 on CHIMERIX INC|
Txns:
| Granted 21,000 options to buy
@ $3.37, valued at
$70.8k
|
|
| 03/12/2019 |
4
| Renaud Ronald C JR (CEO) has filed a Form 4 on Translate Bio, Inc.|
Txns:
| Granted 500,000 options to buy
@ $7.95, valued at
$4M
|
|
| 07/03/2018 |
4
| Renaud Ronald C JR (See Remarks) has filed a Form 4 on Translate Bio, Inc.|
Txns:
| Converted 40,909 shares
@ $0
Converted 227,272 preferred shares
@ $0 |
|
| 06/27/2018 |
3
| Renaud Ronald C JR (See Remarks) has filed a Form 3 on Translate Bio, Inc. |
| 06/21/2018 |
4
| Renaud Ronald C JR (Director) has filed a Form 4 on CHIMERIX INC|
Txns:
| Granted 21,000 options to buy
@ $4.82, valued at
$101.2k
|
|
| 06/15/2018 |
4
| Renaud Ronald C JR (Director) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Granted 12,500 options to buy
@ $11.14, valued at
$139.3k
|
|
| 06/29/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/19/2017 |
4
| Renaud Ronald C JR (Director) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Granted 12,500 options to buy
@ $14.37, valued at
$179.6k
|
|
| 01/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/28/2016 |
4
| Renaud Ronald C JR (Director) has filed a Form 4 on CHIMERIX INC |
| 06/20/2016 |
4
| Renaud Ronald C JR (Director) has filed a Form 4 on Akebia Therapeutics, Inc. |
| 01/06/2016 |
4
| Renaud Ronald C JR (Director) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Granted 12,000 options to buy
@ $30.86, valued at
$370.3k
|
|
| 06/24/2015 |
4
| Renaud Ronald C JR (Director) has filed a Form 4 on CHIMERIX INC|
Txns:
| Granted 9,000 options to buy
@ $45.15, valued at
$406.4k
|
|
| 06/12/2015 |
4
| Renaud Ronald C JR (Director) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Granted 5,000 options to buy
@ $7.86, valued at
$39.3k
|
|
| 01/02/2015 |
4
| Renaud Ronald C JR (Director) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Granted 12,000 options to buy
@ $51, valued at
$612k
|
|
| 12/18/2014 |
4
| Renaud Ronald C JR (Director) has filed a Form 4 on CHIMERIX INC|
Txns:
| Granted 18,000 options to buy
@ $36.59, valued at
$658.6k
|
|
| 12/02/2014 |
4
| Renaud Ronald C JR (Director) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Bought 5,000 shares
@ $11.9173, valued at
$59.6k
|
|
| 09/15/2014 |
4
| Renaud Ronald C JR (Director) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $21.08, valued at
$210.8k
|
|
| 08/05/2014 |
4
| Renaud Ronald C JR (President & CEO) has filed a Form 4 on IDENIX PHARMACEUTICALS INC|
Txns:
| Disposed/sold 225,000 options to buy
@ $6.12, valued at
$1.4M
Disposed/sold 10 options to buy
@ $2.41, valued at
$24.1
Disposed/sold 80,000 options to buy
@ $5.18, valued at
$414.4k
Disposed/sold 110,000 options to buy
@ $5.46, valued at
$600.6k
Disposed/sold 65,000 options to buy
@ $2.96, valued at
$192.4k
Disposed/sold 300,000 options to buy
@ $4.28, valued at
$1.3M
Disposed/sold 300,000 options to buy
@ $3.14, valued at
$942k
Disposed/sold 375,000 options to buy
@ $11.93, valued at
$4.5M
Disposed/sold 500,000 options to buy
@ $4.61, valued at
$2.3M
Disposed/sold 400,000 options to buy
@ $7.23, valued at
$2.9M
|
|
|